ANBL1232 Response & Biology Risk Factors in Patients with Non-High-Risk Neuroblastoma



Subscribe to be notified of changes or updates to this page.

9 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

In this study we are using new biologic features, in addition to the standard risk factors, to help decide which subjects need treatment and what the best treatment is. (Subjects are people who agree to take part in this study.) Subjects will be put into 1 of 3 different treatment groups, labeled as Group A, B and C. The group that you are put in will determine the treatment that you get.

Who Do I Contact?

If you are interested in participating in the study or want to learn more please contact our study team at bagatellr [at] or 215-590-2299.

Eligibility & Criteria

IRB #:
Official Title:
ANBL1232 Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High- Risk Neuroblastoma
Study Phase:
Not Applicable
Eligible Age Range:
0 - 18 Months
Study Categories: